logo
Salud por Derecho
Eng
  • Esp
  • Eng
logo
  • ABOUT US
  • WHAT WE DO
  • COLLABORATE
  • NEWS
Imagen destacada
Home Slider
Nine countries from the OECD attempt to block the success a key resolution that aims to secure price transparency for medications, and the research and development
13/05/2019 by Salud in Home Slider

Doctors without Borders and Salud por Derecho have reported that nine countries attempt to derail the resolution intended to improve price transparency in medication, vaccination and other health technology markets, which is looking to be approved at the next World Health Organization conference.

Barcelona, Madrid, Geneva. May 10, 2019 – The state members of the European Union are negotiating the context of the resolution that aims to improve market transparency for medications, vaccinations and other health technologies and will be proposed at the upcoming WHO conference on May 20th – 28th.

The resolution was proposed by Italy in February 2019 and is currently implemented by ten countries: Slovenia, Spain, Greece, Italy, Malaysia, Portugal, Serbia, South Africa, Turkey and Uganda. If approved, this resolution would be a huge stepping stone towards ensuring affordable prices for essential medications globally.

Nowadays, the lack of transparency surrounding the varying prices paid by different countries for medications and the real cost of research, development and production of those pharmaceuticals, perpetuates the issue the resolution hopes to address—the exorbitant and arbitrary prices that the pharmaceutical industry continues to charge.

Within a draft of the resolution, which was filtered on May 7th during the negotiations among the state members, we observe an attempt made by nine countries, including Germany, the United Kingdom, Switzerland and Denmark, to significantly simplify the language, eliminating key points, around the issue with the lack of transparency. The changes proposed by these countries have been analyzed by the NGO Knowledge Ecology International.

Motivated by the possibility of reintroducing the informal negotiations made in Geneva, more than a hundred civil society organizations and health experts, including Doctors without Borders and the Rights to Health Foundation, contributed to an open letter to the state members of the World Health Organization to insist that they eliminate the detrimental changes introduced to the resolution, which would derail the proposal, producing an inconsequential document.

 

Doctors without Borders/The Access Campaign’s Declaration

“It is disconcerting to see that Germany, the United Kingdom, Switzerland and another five countries from the OECD are attempting to derail this vital movement towards implementing market transparency for the prices of medications and the cost of the current research and development system.

This attempt threatens the efforts necessary to ensure lower prices for medications and an increase in access to treatment for all persons. The exorbitant and arbitrary prices for medications is a prime issue that affects all countries. Hundreds of thousands of people who urgently need these medications are unable to receive them due to excessive pricing, generating unnecessary pressures on the health systems already doomed for collapse.

It is hypocritical of these governments to defend the importance of transparency in almost all other sectors, but, in this case, to go against the current.

These governments should ensure the right to affordable medication and treatment for the people, instead of favoring the agendas that produce maximum benefit for the pharmaceutical corporations. We insist that all of  the countries implicated in these negotiations cease any attempts to dilute the resolution and work together to guarantee that the world population remains alive and healthy with access to treatments and medications at prices it can afford.”

Els Torreele, Executive Director of the Access Campaign (Doctors without Borders)

 

Salud por Derecho’s Declaration 

“We recognize the important step Spain have taken by committing to support the transparency resolution proposed at the WHO conference. In order to augment governments’ power in negotiations with the pharmaceutical industry, transparency is fundament in the prices of medications, the real cost of research and development, and the use of public investments.” 

Vanessa López, Executive Director of Salud por Derecho.

Compartir:
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
Linkedin
Share on email
Email
Share on whatsapp
Whatsapp
Salud

Search

Subscribe to Newsletter

Estoy de acuerdo con la Política de privacidad.

LOCATION

Salud por Derecho
Duque Fernán Núñez, 2.
28012 Madrid
saludporderecho@saludporderecho.org

facebook twitter youtube

ABOUT US

About us

What we do

Collaborate

News

Privacy Policy

Cookie Policy

Publications

Press Area

SUBSCRIBE TO OUR NEWSLETTER

Estoy de acuerdo con la Política de privacidad.

Compartir:
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
Linkedin
Share on email
Email
Share on whatsapp
Whatsapp
logo
Política de Cookies
Esta web utiliza cookies propias y de terceros para analizar tu navegación y ofrecerte un servicio más personalizado acorde a tus intereses. Continuar navegando implica la aceptación de nuestra Política de Cookies. También hemos actualizado nuestra Política de Privacidad para adecuarnos a la nueva normativa europea, puedes consultarla en la web. Aceptar Rechazar
Política de Cookies

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT